Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07034677
PHASE4
Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism
Sponsor: Lars Rejnmark
View on ClinicalTrials.gov
Summary
The aim of this study is to investigate the effect of daily treatment with Indapamide for 14 days on urinary calcium excretion in patients with post surgical hypoparathyroidisme.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2025-08
Completion Date
2025-12
Last Updated
2025-08-11
Healthy Volunteers
No
Conditions
Interventions
DRUG
Indapamide 1.5 MG SR
14 days treatment with indapamide 1.5 mg/day compared to placebo
DRUG
Placebo
14 days treatment with placebo
Locations (1)
Department of Endocrinology and Internal Medicine
Aarhus, Denmark